Intravascular stent versus stent combined with 125I seed strip implantation in the treatment of superior vena cava syndrome
10.3969/j.issn.1008-794X.2024.06.009
- VernacularTitle:血管内支架与支架联合125I粒子条治疗上腔静脉综合征
- Author:
Yanwei QIN
1
;
Hongru MA
;
Jie CHEN
;
Junbiao LI
;
Yan LI
;
Yong WANG
;
Wei XU
Author Information
1. 221006 江苏徐州 徐州医科大学附属医院介入放射科
- Keywords:
superior vena cava syndrome;
125I seed;
intravascular stent
- From:
Journal of Interventional Radiology
2024;33(6):632-635
- CountryChina
- Language:Chinese
-
Abstract:
Objective To evaluate the clinical safety and effectiveness of intravascular stent combined with 125I seed strip implantation in the treatment of superior vena cava syndrome(SVCS)caused by malignant tumors.Methods The clinical data of 43 patients with SVCS,who were admitted to the Affiliated Hospital of Xuzhou Medical University of China from May 2017 to October 2022,were retrospective analyzed.Of the 43 patients,27 received intravascular stent combined with l25I seed strip implantation(observation group),and 16 received simple intravascular stent implantation(control group).The stent patency rate,clinical symptom relief rate,and survival time were compared between the two groups.Results Successful operation was accomplished in all the 43 patients.In the observation group,the postoperative 3-month stent patency rate and average survival time were 88.7％and 39.1 weeks respectively,which were significantly higher than 62.5％and 21.8 weeks respectively in the control group,the differences between the two groups were statistically significant(P=0.033 and P=0.035 respectively).After treatment,all the clinical symptoms were relieved.Conclusion For the treatment of SVCS,intravascular stent combined with 125I seed strip implantation is clinically safe and effective,it can be used as the preferred treatment option.(J Intervent Radiol,2024,33:632-635)
